Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and nadifloxacin

levofloxacin has been researched along with nadifloxacin in 4 studies

Compound Research Comparison

Studies
(levofloxacin)		Trials
(levofloxacin)		Recent Studies (post-2010)
(levofloxacin)		Studies
(nadifloxacin)		Trials
(nadifloxacin)		Recent Studies (post-2010) (nadifloxacin)
4,3465812,209761133

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Appelbaum, PC; Bhawsar, SB; Bozdogan, B; de Souza, NJ; Desai, VN; Deshpande, PK; Gupte, SV; Hooper, DC; Jacobs, MR; Jha, R; Khorakiwala, HF; Patel, MV; Shetty, N; Shukla, MC; Strahilevitz, J; Yeole, RD1
Hayashi, K; Mitsuyama, J; Yamakawa, T1
Amano, A; Ikeda, F; Ishii, R; Kanayama, S; Matsumoto, S; Matsumoto, T; Matsuzaki, K; Nakajima, A; Okamoto, K1
Nakaminami, H; Nakase, K; Noguchi, N; Sakuma, Y1

Other Studies

4 other study(ies) available for levofloxacin and nadifloxacin

ArticleYear
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
    Journal of medicinal chemistry, 2005, Aug-11, Volume: 48, Issue:16

    Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance

2005
In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:3

    Topics: Animals; Anti-Infective Agents; Clindamycin; Colony Count, Microbial; DNA Topoisomerase IV; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gene Frequency; Genes, Bacterial; Gentamicins; Levofloxacin; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mutation; Ofloxacin; Quinolines; Quinolizines; Staphylococcal Skin Infections; Staphylococcus aureus; Staphylococcus epidermidis; Topoisomerase II Inhibitors

2002
In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:10

    Topics: Administration, Cutaneous; Adolescent; Adult; Aminopyridines; Anti-Bacterial Agents; Child; Female; Fluoroquinolones; Humans; Japan; Levofloxacin; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolizines; Quinolones; Skin Cream; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Streptococcus pyogenes

2016
Emergence of fluoroquinolone-resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IV.
    Anaerobe, 2016, Volume: 42

    Topics: Acne Vulgaris; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Propionibacterium acnes; Quinolizines

2016